E

Enlivex Therapeutics Ltd
D

ENLV

1.50500
USD
-0.22
(-12.75%)
قبل الجلسة·1.52000USD+0.01500(+1.00%)
حجم التداول
1
الربح لكل سهم
-1
العائد الربحي
-
P/E
0
حجم السوق
26,315,620
أصول ذات صلة المقالات
المزيد

العنوان: Enlivex Ltd

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.